Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase

J Immunol. 2000 Dec 15;165(12):7157-63. doi: 10.4049/jimmunol.165.12.7157.

Abstract

High-dose Ag administration induces apoptotic death of autoreactive T cells and is an effective therapy of experimental autoimmune diseases of the nervous system. To explore the role of cytokines in Ag-specific immunotherapy, we analyzed mRNA induction and protein expression for the proinflammatory cytokines TNF-alpha and IFN-gamma, the anti-inflammatory cytokine IL-10, and the cytokine-inducible NO synthase (iNOS) during high-dose Ag therapy of adoptive transfer experimental autoimmune encephalomyelitis (AT-EAE) in the Lewis rat. Using semiquantitative and competitive RT-PCR, we found 5- to 6-fold induction of TNF-alpha mRNA and 3-fold induction of IFN-gamma mRNA in the spinal cord that occurred within 1 h after i.v. injection of Ag and was accompanied by a 2-fold increase of iNOS mRNA. Both IFN-gamma and iNOS mRNA remained elevated for at least 6 h, whereas TNF-alpha mRNA was already down-regulated 6 h after Ag injection. A comparable time course was found for circulating serum levels of TNF-alpha and IFN-gamma. IL-10 mRNA levels did not change significantly following Ag injection. Neutralization of TNF-alpha by anti-TNF-alpha antiserum in vivo led to a significant decrease in the rate of T cell and oligodendrocyte apoptosis induced by high-dose Ag administration, but did not change the beneficial clinical effect of Ag therapy. Our data suggest profound activation of proinflammatory but not of anti-inflammatory cytokine gene expression by high-dose Ag injection. Functionally, TNF-alpha contributes to increased apoptosis of both autoaggressive T cells and oligodendrocytes in the target organ and may thereby play a dual role in this model of Ag-specific therapy of CNS autoimmune diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / immunology
  • Autoantigens / administration & dosage
  • Autoantigens / therapeutic use*
  • Cell Movement / immunology
  • Cytokines / biosynthesis*
  • Cytokines / blood
  • Disease Progression
  • Dose-Response Relationship, Immunologic
  • Drug Administration Schedule
  • Encephalomyelitis, Autoimmune, Experimental / enzymology
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Encephalomyelitis, Autoimmune, Experimental / therapy*
  • Enzyme Induction / genetics
  • Enzyme Induction / immunology
  • Female
  • Gene Expression Regulation / immunology
  • Guinea Pigs
  • Immune Sera / administration & dosage
  • Injections, Intravenous
  • Myelin Basic Protein / administration & dosage
  • Myelin Basic Protein / immunology*
  • Myelin Basic Protein / therapeutic use*
  • Nitric Oxide Synthase / biosynthesis*
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase Type II
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Inbred Lew
  • Spinal Cord / enzymology
  • Spinal Cord / immunology
  • Spinal Cord / pathology
  • Th1 Cells / immunology
  • Th1 Cells / metabolism*
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Autoantigens
  • Cytokines
  • Immune Sera
  • Myelin Basic Protein
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat